Literature DB >> 29042395

Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer.

Zhu Wang1,2, Dinglan Wu1,3, Chi-Fai Ng4, Jeremy Yuen-Chun Teoh4, Shan Yu1, Yuliang Wang5, Franky L Chan5.   

Abstract

Nuclear receptors (NRs), which belong to a superfamily of transcription factors and consist of a total of 48 members in humans, govern the expression of genes involved in a board range of developmental, reproductive, metabolic and immunological programs. Given the significant importance of androgen receptor and a few known NRs in the progression of prostate cancer, we surveyed the expression profiles of the entire NR superfamily in three-dimensional cultured prostatospheroids derived from different prostate cancer cell lines and a tumor xenograft model of castration-resistant prostate cancer VCaP-CRPC by quantitative real-time RT-PCR. Our results revealed that prostatospheroids and castration-relapse VCaP-CRPC xenografts, both contained enriched populations of prostate cancer stem/progenitor-like cells (PCSCs), displayed distinct expression patterns of NRs. Intriguingly, most of these differentially expressed NRs were orphan NRs and showed upregulation. Pairwise analysis identified five orphan NRs (including RORβ, TLX, COUP-TFII, NURR1 and LRH-1) that showed common upregulation in both mRNA and protein levels in the prostatospheroids and castration-relapse VCaP-CRPC xenografts, and overexpression of these orphan NRs could increase cancer stem cell marker expressions and enhance spheroid formation capacity in prostate cancer cells, suggesting that these orphan NRs might perform positive roles in the growth regulation of PCSCs and castration-resistant prostate cancer. Together, our NR expression dataset not only revealed the distinct physiologic status and regulatory roles governed by the networks of specific NRs but also some of these identified orphan NRs could be the potential therapeutic targets for PCSCs or castration-resistant prostate cancer.
© 2018 Society for Endocrinology.

Entities:  

Keywords:  castration resistance; nuclear receptors; orphan nuclear receptors; prostate cancer; prostate cancer stem-like cells

Mesh:

Substances:

Year:  2017        PMID: 29042395     DOI: 10.1530/ERC-17-0280

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  12 in total

1.  Tumorigenic effects of TLX overexpression in HEK 293T cells.

Authors:  Toshima Z Parris; Dzeneta Vizlin-Hodzic; Susanne Salmela; Keiko Funa
Journal:  Cancer Rep (Hoboken)       Date:  2019-07-25

2.  Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence.

Authors:  Zhu Wang; Youjia Li; Dinglan Wu; Shan Yu; Yuliang Wang; Franky Leung Chan
Journal:  Oncogene       Date:  2019-11-06       Impact factor: 9.867

Review 3.  Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer.

Authors:  Jianfu Zhou; Yuliang Wang; Dinglan Wu; Shusheng Wang; Zhiqiang Chen; Songtao Xiang; Franky Leung Chan
Journal:  Oncogene       Date:  2021-03-09       Impact factor: 9.867

4.  Recent progress on the role and molecular mechanism of chicken ovalbumin upstream promoter-transcription factor II in cancer.

Authors:  Seong-Hoon Yun; Joo-In Park
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

5.  Development of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cells.

Authors:  Weijie Gao; Dinglan Wu; Yuliang Wang; Zhu Wang; Chang Zou; Yong Dai; Chi-Fai Ng; Jeremy Yuen-Chun Teoh; Franky Leung Chan
Journal:  Stem Cell Res Ther       Date:  2018-09-26       Impact factor: 6.832

6.  Computer-Aided Discovery of Small Molecule Inhibitors of Transcriptional Activity of TLX (NR2E1) Nuclear Receptor.

Authors:  Evgenia Dueva; Kriti Singh; Anastasia Kalyta; Eric LeBlanc; Paul S Rennie; Artem Cherkasov
Journal:  Molecules       Date:  2018-11-14       Impact factor: 4.411

7.  Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.

Authors:  Lin Jia; Dinglan Wu; Yuliang Wang; Wenxing You; Zhu Wang; Lijia Xiao; Ganhui Cai; Zhenyu Xu; Chang Zou; Fei Wang; Jeremy Yuen-Chun Teoh; Chi-Fai Ng; Shan Yu; Franky L Chan
Journal:  Oncogene       Date:  2018-03-20       Impact factor: 9.867

8.  Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells.

Authors:  Zhu Wang; Youjia Li; Yuliang Wang; Dinglan Wu; Alaster Hang Yung Lau; Pan Zhao; Chang Zou; Yong Dai; Franky Leung Chan
Journal:  Stem Cell Res Ther       Date:  2020-03-17       Impact factor: 6.832

9.  In Vitro and In Vivo Antitumor Activity of Cucurbitacin C, a Novel Natural Product From Cucumber.

Authors:  Dinglan Wu; Zhu Wang; Muqi Lin; Yi Shang; Fei Wang; JiaYi Zhou; Fei Wang; Xiantong Zhang; Xiaomin Luo; Weiren Huang
Journal:  Front Pharmacol       Date:  2019-11-08       Impact factor: 5.810

10.  Orphan nuclear receptor Nurr1 promotes Helicobacter pylori-associated gastric carcinogenesis by directly enhancing CDK4 expression.

Authors:  Wenjing Shang; Xiuming Liang; Shuyan Li; Tongyu Li; Lixin Zheng; Wei Shao; Yue Wang; Fen Liu; Lin Ma; Jihui Jia
Journal:  EBioMedicine       Date:  2020-02-27       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.